

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>GOLD\Example Study RAAINBOW - JSON Representation - FHIR v4.0.1</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/hl7.css" rel="stylesheet"/>
    <link href="assets/css/fhir.css" rel="stylesheet"/>

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"7.62"}
    h3,h4,h5,h6{--heading-prefix:"7.62"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->

            <!-- Right logo -->
<div id="family-nav">
    <a id="family-logo" no-external="true" href="https://www.vision-zero-oncology.de/">
      <img height="70" alt="Vision Zero website" src="vision-zero-logo.svg" />
    </a>
  </div>

            <div id="hl7-nav">
    <a id="logo" no-external="true" href="https://vision-zero-oncology.github.io/GOLD/">
        <img alt="visit the website" height="60" src="gold-logo-text.png" />
    </a>            
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">German Oncological Data Standard (GOLD)</span>
            <br/>
            <span style="display:inline-block;">0.1.0 - CI Build



  <img alt="Germany flag" src="assets/images/deu.svg" height="16" title="Germany"/>


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <!--<li><a href="toc.html">Table of Contents</a></li>-->
  <li>
    <a href="index.html">Home</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">
      Background
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="logicalmodel.html">Logical Model</a>
      </li>
      <li>
        <a href="usecase.html">Use Case</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="profiles.html">Profiles</a>
  </li>
  <li>
    <a href="extensions.html">Extensions</a>
  </li>
  <li>
    <a href="terminology.html">Terminology</a>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>Example Study RAAINBOW</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div style="counter-reset: section 8" class="col-12">
<!--ReleaseHeader--><p id="publish-box">German Oncological Data Standard (GOLD) - Local Development build (v0.1.0). See the <a href="https://www.vision-zero-oncology.de/fhir/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->









<ul class="nav nav-tabs">

  <li>
    <a href="ResearchStudy-ExampleStudyRAAINBOW.html">Narrative Content</a>
  </li>



  
    <li>
      <a href="ResearchStudy-ExampleStudyRAAINBOW.xml.html">XML</a>
    </li>
  


  
    <li class="active">
      <a href="#">JSON</a>
    </li>
  


  
    <li>
      <a href="ResearchStudy-ExampleStudyRAAINBOW.ttl.html">TTL</a>
    </li>
  



</ul>


<a name="root"> </a>


<h2 id="root">: Example Study RAAINBOW - JSON Representation</h2>
  <table class="">
    <tr>

      <td colspan="2">
        
          
          
        
      </td>

    </tr>
  </table>


<p><a href="ResearchStudy-ExampleStudyRAAINBOW.json" no-download="true">Raw json</a> | <a href="ResearchStudy-ExampleStudyRAAINBOW.json" download>Download</a></p>

  <!-- insert intro if present -->
  



  <pre class="json" style="white-space: pre; overflow: hidden"><code>
{
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy">resourceType</a>" : "ResearchStudy",
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.id">id</a>" : "ExampleStudyRAAINBOW",
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.meta">meta</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Meta#Meta.profile">profile</a>" : [
      "https://www.vision-zero-oncology.de/fhir/StructureDefinition/clinical-study"
    ]
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.text">text</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.status">status</a>" : "generated",
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.div">div</a>" : "&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;&lt;b&gt;Generated Narrative: ResearchStudy&lt;/b&gt;&lt;a name=\&quot;ExampleStudyRAAINBOW\&quot;&gt; &lt;/a&gt;&lt;/p&gt;&lt;div style=\&quot;display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\&quot;&gt;&lt;p style=\&quot;margin-bottom: 0px\&quot;&gt;Resource ResearchStudy &amp;quot;ExampleStudyRAAINBOW&amp;quot; &lt;/p&gt;&lt;p style=\&quot;margin-bottom: 0px\&quot;&gt;Profile: &lt;a href=\&quot;StructureDefinition-clinical-study.html\&quot;&gt;Profile Clinical Study&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;identifier&lt;/b&gt;: id:\u00a0NCT03240627&lt;/p&gt;&lt;p&gt;&lt;b&gt;title&lt;/b&gt;: Double-blind, Vehicle-controlled, Randomised, Multi-centre Study to Evaluate the Efficacy and Safety of LH-8 Cutaneous Solution in Children and Adolescents With Moderate to Severe Scalp Alopecia Areata.&lt;/p&gt;&lt;p&gt;&lt;b&gt;status&lt;/b&gt;: completed&lt;/p&gt;&lt;p&gt;&lt;b&gt;primaryPurposeType&lt;/b&gt;: Treatment &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-prim-purp-type.html\&quot;&gt;ResearchStudyPrimaryPurposeType&lt;/a&gt;#treatment)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;phase&lt;/b&gt;: Phase 2/Phase 3 &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-phase.html\&quot;&gt;ResearchStudyPhase&lt;/a&gt;#phase-2-phase-3)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;category&lt;/b&gt;: Interventional Study &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C98388)&lt;/span&gt;, Randomized Controlled Clinical Trial &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C46079)&lt;/span&gt;, Double Blind Study &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C15228)&lt;/span&gt;, Unequal Randomization &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C142743)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;focus&lt;/b&gt;: Pharmacologic Substance &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C1909)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;condition&lt;/b&gt;: Alopecia areata (disorder) &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;https://browser.ihtsdotools.org/\&quot;&gt;SNOMED CT&lt;/a&gt;#68225006)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;location&lt;/b&gt;: Germany &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\&quot;&gt;ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code&lt;/a&gt;#DE)&lt;/span&gt;, France &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\&quot;&gt;ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code&lt;/a&gt;#FR)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;period&lt;/b&gt;: 2018-03-01 --&amp;gt; 2022-03-17&lt;/p&gt;&lt;p&gt;&lt;b&gt;principalInvestigator&lt;/b&gt;: &lt;a href=\&quot;https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Practitioner/example\&quot;&gt;Practitioner/example&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;site&lt;/b&gt;: &lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a href=\&quot;https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Organization/Charite-dermatology\&quot;&gt;Organization/Charite-dermatology&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href=\&quot;https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Organization/Sabouraud-Center\&quot;&gt;Organization/Sabouraud-Center&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href=\&quot;https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Organization/Diagnostic-consulting-center-XXIV-Sofia\&quot;&gt;Organization/Diagnostic-consulting-center-XXIV-Sofia&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href=\&quot;https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Organization/SC-Centrul-Medical-Sana-SRL\&quot;&gt;Organization/SC-Centrul-Medical-Sana-SRL&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;arm&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Experimental: LH-8 cutaneous solution&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Investigational Arm &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C174266)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;description&lt;/b&gt;: LH-8 cutaneous solution (0.126 mL per spray) applied to the whole scalp&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;arm&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Placebo Comparator: Placebo cutaneous solution&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Control Arm &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-v3-nciThesaurus.html\&quot;&gt;NCI Thesaurus&lt;/a&gt;#C174226)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;description&lt;/b&gt;: Placebo cutaneous solution (0.126 mL per spray) applied to the whole scalp&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Relative change in scalp alopecia areata severity scores (SALT) from baseline value to be assessed after 24 weeks of treatment. [ Time Frame: 24 weeks treatment ] Visual assessment and global standardised scalp photographs for SALT evaluation.&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Primary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#primary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Absolute change in SALT score from baseline at the end of 24 weeks' treatment period. [ Time Frame: 24 weeks treatment ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Proportion of the responders, i.e. subjects achieving at least a 40% relative reduction in SALT score from baseline at the end of 24 weeks' treatment period. [ Time Frame: 24 weeks treatment ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Adverse events [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: General physical examination findings, including irritation of eyes and skin [ Time Frame: 24 weeks treatment ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Visual assessment and global standardised scalp photographs for SALT evaluation. [ Time Frame: After 12 and 24 weeks treatment ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Evaluation of duration of treatment effect in responders, measured as relative SALT score changes from Visit 3 (end of treatment) after 12 weeks (Visit 4) and 24 weeks (Visit 5) of treatment-free period. (Visual assessment and global standardised scalp photographs for SALT evaluation.)&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Assessment of treatment effect on hair follicles in non-alopecic areas by quantifying the number of new alopecic areas. [ Time Frame: 24 weeks treatment ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Assessment of the rate of spontaneous hair regrowth. [ Time Frame: For 6-12 months ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Assessment of the rate of spontaneous hair regrowth in placebo treated subjects with alopecia areata active for 6-12 months compared to those with alopecia areata active for more than 12 months. (Visual assessment and global standardised scalp photographs for SALT evaluation).&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Absolute and relative change from baseline in Children's Dermatology Life Quality Index (CDLQI) scores. [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Change in percentage of subjects from baseline by the severity banding CDLQI scores. [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Percentages of subjects by EuroQol Five Dimensions Youth Questionnaire (EQ-5D-Y) dimensions and levels at Visits 1-5. [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Absolute and relative change of the EQ-Visual Analogue Scale (EQ-VAS) scores from baseline [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;blockquote&gt;&lt;p&gt;&lt;b&gt;objective&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;name&lt;/b&gt;: Evaluation of the Paediatric Alopecia Areata Patient Benefit Index (PAAPBI) scores at Visits 1 to 5. [ Time Frame: 48 weeks ]&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Secondary &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (&lt;a href=\&quot;http://terminology.hl7.org/5.0.0/CodeSystem-research-study-objective-type.html\&quot;&gt;ResearchStudyObjectiveType&lt;/a&gt;#secondary)&lt;/span&gt;&lt;/p&gt;&lt;/blockquote&gt;&lt;/div&gt;"<a name="end-xhtml"></a>
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.identifier">identifier</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#Identifier#Identifier.system">system</a>" : "http://clinicaltrials.gov",
      "<a href="http://hl7.org/fhir/R4/datatypes.html#Identifier#Identifier.value">value</a>" : "NCT03240627"
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.title">title</a>" : "Double-blind, Vehicle-controlled, Randomised, Multi-centre Study to Evaluate the Efficacy and Safety of LH-8 Cutaneous Solution in Children and Adolescents With Moderate to Severe Scalp Alopecia Areata.",
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.status">status</a>" : "completed",
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.primaryPurposeType">primaryPurposeType</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
      {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-prim-purp-type",
        "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "treatment"
      }
    ]
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.phase">phase</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
      {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-phase",
        "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "phase-2-phase-3",
        "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Phase 2/Phase 3"
      }
    ]
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.category">category</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C98388",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Interventional Study"
        }
      ]
    },
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C46079",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Randomized Controlled Clinical Trial"
        }
      ]
    },
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C15228",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Double Blind Study"
        }
      ]
    },
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C142743",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Unequal Randomization"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.focus">focus</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C1909",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Pharmacologic Substance"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.condition">condition</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://snomed.info/sct",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "68225006",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Alopecia areata (disorder)"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.location">location</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "urn:iso:std:iso:3166",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "DE",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Germany"
        }
      ]
    },
    {
      "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "urn:iso:std:iso:3166",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "FR",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "France"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.period">period</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Period#Period.start">start</a>" : "2018-03-01",
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Period#Period.end">end</a>" : "2022-03-17"
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.principalInvestigator">principalInvestigator</a>" : {
    "<a href="http://hl7.org/fhir/R4/references.html#Reference#Reference.reference">reference</a>" : "Practitioner/example"
  },
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.site">site</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/references.html#Reference#Reference.reference">reference</a>" : "Organization/Charite-dermatology"
    },
    {
      "<a href="http://hl7.org/fhir/R4/references.html#Reference#Reference.reference">reference</a>" : "Organization/Sabouraud-Center"
    },
    {
      "<a href="http://hl7.org/fhir/R4/references.html#Reference#Reference.reference">reference</a>" : "Organization/Diagnostic-consulting-center-XXIV-Sofia"
    },
    {
      "<a href="http://hl7.org/fhir/R4/references.html#Reference#Reference.reference">reference</a>" : "Organization/SC-Centrul-Medical-Sana-SRL"
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm">arm</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.name">name</a>" : "Experimental: LH-8 cutaneous solution",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C174266",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Investigational Arm"
          }
        ]
      },
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.description">description</a>" : "LH-8 cutaneous solution (0.126 mL per spray) applied to the whole scalp"
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.name">name</a>" : "Placebo Comparator: Placebo cutaneous solution",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "C174226",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.display">display</a>" : "Control Arm"
          }
        ]
      },
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.arm.description">description</a>" : "Placebo cutaneous solution (0.126 mL per spray) applied to the whole scalp"
    }
  ],
  "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective">objective</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Relative change in scalp alopecia areata severity scores (SALT) from baseline value to be assessed after 24 weeks of treatment. [ Time Frame: 24 weeks treatment ] Visual assessment and global standardised scalp photographs for SALT evaluation.",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "primary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Absolute change in SALT score from baseline at the end of 24 weeks' treatment period. [ Time Frame: 24 weeks treatment ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Proportion of the responders, i.e. subjects achieving at least a 40% relative reduction in SALT score from baseline at the end of 24 weeks' treatment period. [ Time Frame: 24 weeks treatment ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Adverse events [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "General physical examination findings, including irritation of eyes and skin [ Time Frame: 24 weeks treatment ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Visual assessment and global standardised scalp photographs for SALT evaluation. [ Time Frame: After 12 and 24 weeks treatment ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Evaluation of duration of treatment effect in responders, measured as relative SALT score changes from Visit 3 (end of treatment) after 12 weeks (Visit 4) and 24 weeks (Visit 5) of treatment-free period. (Visual assessment and global standardised scalp photographs for SALT evaluation.)",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Assessment of treatment effect on hair follicles in non-alopecic areas by quantifying the number of new alopecic areas. [ Time Frame: 24 weeks treatment ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Assessment of the rate of spontaneous hair regrowth. [ Time Frame: For 6-12 months ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Assessment of the rate of spontaneous hair regrowth in placebo treated subjects with alopecia areata active for 6-12 months compared to those with alopecia areata active for more than 12 months. (Visual assessment and global standardised scalp photographs for SALT evaluation).",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Absolute and relative change from baseline in Children's Dermatology Life Quality Index (CDLQI) scores. [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Change in percentage of subjects from baseline by the severity banding CDLQI scores. [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Percentages of subjects by EuroQol Five Dimensions Youth Questionnaire (EQ-5D-Y) dimensions and levels at Visits 1-5. [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Absolute and relative change of the EQ-Visual Analogue Scale (EQ-VAS) scores from baseline [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    },
    {
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.name">name</a>" : "Evaluation of the Paediatric Alopecia Areata Patient Benefit Index (PAAPBI) scores at Visits 1 to 5. [ Time Frame: 48 weeks ]",
      "<a href="http://hl7.org/fhir/R4/researchstudy.html#ResearchStudy.objective.type">type</a>" : {
        "<a href="http://hl7.org/fhir/R4/datatypes.html#CodeableConcept#CodeableConcept.coding">coding</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.system">system</a>" : "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
            "<a href="http://hl7.org/fhir/R4/datatypes.html#Coding#Coding.code">code</a>" : "secondary"
          }
        ]
      }
    }
  ]
}</code></pre>


  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2021+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.bihealth.org/">Berlin Institute of Health at Charité (BIH)</a>.  Package gold#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Tue, Apr 11, 2023 09:33+0000">2023-04-11</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                

          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
<!-- feedback form - Google forms -->
<!-- v0.1, 2021-01-09 -->



<!-- / feedback form  -->

  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

